Anjarium Biosciences
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $61M
Investors
- 5
About Anjarium Biosciences
Based in Zurich, Switzerland, and founded in 2017, Anjarium Biosciences AG provides a novel class of bioinspired nanomedicine. Anjarium Biosciences AG’s platform builds on novel therapeutic payloads and delivery technologies and also aims to unlock the full potential of gene therapy.
Who invested in Anjarium Biosciences
5 investors across 1 round
See all investors in Anjarium Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 15, 2021
Amount
$61M
Investors
Questions about Anjarium Biosciences
Who invested in Anjarium Biosciences?
Anjarium Biosciences has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anjarium Biosciences raised?
Anjarium Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anjarium Biosciences last raise money?
Anjarium Biosciences's most recent round on record is a Series A, in Sep 2021.
What does Anjarium Biosciences do?
Based in Zurich, Switzerland, and founded in 2017, Anjarium Biosciences AG provides a novel class of bioinspired nanomedicine.
Where is Anjarium Biosciences headquartered?
Anjarium Biosciences is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Anjarium Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Anjarium Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Anjarium Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.